January 16th, 2007, 01:45 PM
Join Date: Jun 2006
Hunting a chikungunya vaccine
|By Clare Kittredge|
|Hunting a chikungunya vaccine|
French scientists begin safety testing of vaccine to quell ever-growing outbreak of the mosquito virus
[Published 16th January 2007 02:35 PM GMT]
|As the Indian Ocean region continues to grapple with the largest recorded outbreak of the mosquito virus chikungunya, scientists in France have started laboratory safety testing of a chikungunya vaccine developed and abandoned years ago by the U.S. Army, then recently passed on to the French. |
If no prions or other contaminants are found in the U.S. vaccine, French scientists plan clinical trials next fall, according to Antoine Flahault, head of France's Chikungunya Research Task Force and director of France's new School of Public Health (Ecole des Hautes Etudes en Sante Publique). The first study would start in France next September in 100 Parisian hospital workers, followed two months later by a study of 500 volunteers in Reunion, a French island near Madagascar where a third of the population has been infected (266,000 cases, 250 deaths). A study in macaque monkeys, native to nearby Mauritius, is also planned.
Although vaccine development is notoriously fickle, "using the U.S. vaccine will save us five years," Flahault told The Scientist, adding that Sanofi Pasteur plans to produce the vaccine commercially. "The Americans were very lucky to discover a promising vaccine strain... If all goes well, the commercial vaccine will be available in five years."
Chikungunya was until recently a little-known mosquito-borne alphavirus that causes few deaths but leads to debilitating joint pain, fever and arthritic symptoms. Isolated in 1953 in Tanzania, the virus sparked sporadic epidemics in Africa and Asia.
The latest outbreak has been traced to a viral strain that surfaced in Kenya in 2004, spread to the Comoros and Reunion in 2005 and 2006, and has the same genomic sequence as the virus that has caused 1.5 million cases in India, said Flahault.
In the late seventies, U.S. Army scientists at the Walter Reed Army Institute of Research and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) started developing the only known chikungunya vaccine tested on humans, a live attenuated vaccine created from an isolate taken from a patient in Thailand. The research stopped in 1997 despite promising phase II study results (57 out of 58 evaluable vaccinees developed a neutralizing antibody by day 28, and 85% were seropositive a year later) due to lack of a commercial partner, changing budget priorities, and "difficulty envisioning how final field efficacy trials would be conducted due to the unpredictable nature of chikungunya outbreaks," said Col. David Vaughn, outgoing director of the Military Infectious Diseases Research Program at the U.S. Army Medical Research and Materiel Command in Fort Detrick, Maryland.
"Chikungunya tends to have fairly explosive outbreaks, but only every few years, so it's a more unpredictable market than other tropical diseases," Vaughn told The Scientist. "But if we had a million cases as they do in India...we'd be focusing on it."
So far, the CDC has identified 40 or 50 cases imported to the U.S. by travelers to India, said molecular virologist Ann Powers, Chief of the Alphavirus Laboratory with the CDC's Division of Vector-Borne Infectious Diseases in Fort Collins. In September, 2006, the U.S. Embassy in Paris announced a U.S. Government agreement to transfer research records, vaccine supplies, and seed stocks so the French could resume vaccine development. The cooperative deal involves a partnership between the U.S. Military and other agencies, the French Ministry of Health, INSERM, and the Institut Pasteur. Flahault said that he did not believe the two countries had struck a commercial agreement. Vaughn, meanwhile, said if the vaccine proves effective, "a licensure agreement between USAMRIID and a commercial manufacturer will be needed."
Because it was grown in cells fed calf serum, the U.S. vaccine is being tested for the prions that cause bovine spongiform encephalopathy, Flahault said.
The epidemic also sparked interest in India, where scientists are reportedly also working on a chikungunya vaccine. Indian scientists did not respond to requests for comment.
Links within this article:
CDC Outbreak Notice Update: "Chikungunya Fever: India and Indian Ocean Islands," released April 21, 2006, last updated Oct. 24, 2006
C. Kittredge, "Mosquito virus spreading," The Scientist, Feb. 24, 2006
Antoine Flahault, recent publications listed in PubMed
Paul Reiter et al, "Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem?" The Lancet, August, 2006
Isabelle Schuffenecker et al, "Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak," PLoS MEDICINE, July, 2006
Christophe Paquet et al, "Chikungunya Disease Outbreak, Reunion Island," CDC Emerging Infectious Diseases, December, 2006
U.S. Embassy, Paris, press release, "US-France Cooperation On Chikungunya Vaccine," Sept. 14, 2006
World Heath Organization, "Chikungunya Fever, a re-emerging Disease in Asia" http://www.searo.who.int/en/Section10/Section2246.htm
V. Narayanan, "Private lab files patent for chikungunya vaccine," News Today, Oct. 25, 2006
Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is On
The reader is responsible for discerning the validity, factuality or implications of information posted here, be it fictional or based on real events. Moderators on this forum make every effort to review the material posted on this site however, it is not realistically possible for our staff to manually review each post.
The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original authors or posters and are not endorsed by, or representative of the opinions of, the owners or administration of this website. The posts on this website are the opinion of the specific author or poster and should not be construed as statements of advice or factual information.
Not all posts on this website are intended as truthful or factual assertion by their authors. NO posts on this website should be considered factual information on face value alone. Users are encouraged to USE DISCERNMENT and do their own follow up research while reading and posting on this website. FluTrackers.com Inc. reserves the right to make changes to, corrections and/or remove entirely at any time posts made on this website without notice. In addition, FluTrackers.com Inc. disclaims any and all liability for damages incurred directly or indirectly as a result of a post on this website.
This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall FluTrackers.com Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.
Finally, FluTrackers.com Inc. reserves the right to delete, correct, or make changes to any post on this website without notice at any time for any reason.
Fair Use Notice:
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to public health, civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes.
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 1 paragraph, and in no case more than 50% of the source material provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember you are responsible for what you post on the internet and you could be sued by the original copyright holder if you do not honor these rules.
If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright
we may be contacted concerning copyright matters at:
c/o Sharon Sanders
1676 Hibiscus Avenue
Winter Park, Florida 32789
In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is the copyright of the respective owners / authors. FluTrackers.com Inc. makes no claim of copyright on such material.
For more information please visit:
Please be aware any communications sent complaining about a post on this website may be posted publicly at the discretion of the administration.
FluTrackers Does Not Provide Any Medical Advice:
FluTrackers, Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
By using and/or accessing this site, either passively or actively, you are agreeing to all of the above conditions. Also, by using and/or accessing this site, either passively or actively, you agree to conduct all business and legal affairs related to this website in the jurisdiction of Flutrackers.com Inc. which is registered in Central Florida, USA.
These Disclaimers are subject to change at anytime.
Email the Webmaster with questions or comments about this site at email@example.com
All times are GMT -5. The time now is 07:33 AM.